CA2515677A1 - Procedes pour controler in vivo des activites de medicaments - Google Patents
Procedes pour controler in vivo des activites de medicaments Download PDFInfo
- Publication number
- CA2515677A1 CA2515677A1 CA002515677A CA2515677A CA2515677A1 CA 2515677 A1 CA2515677 A1 CA 2515677A1 CA 002515677 A CA002515677 A CA 002515677A CA 2515677 A CA2515677 A CA 2515677A CA 2515677 A1 CA2515677 A1 CA 2515677A1
- Authority
- CA
- Canada
- Prior art keywords
- gene
- encodes
- cps
- seq
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44613303P | 2003-02-11 | 2003-02-11 | |
| US60/446,133 | 2003-02-11 | ||
| US45978203P | 2003-04-03 | 2003-04-03 | |
| US60/459,782 | 2003-04-03 | ||
| US53824604P | 2004-01-23 | 2004-01-23 | |
| US60/538,246 | 2004-01-23 | ||
| PCT/US2004/004118 WO2004072265A2 (fr) | 2003-02-11 | 2004-02-11 | Procedes pour controler in vivo des activites de medicaments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2515677A1 true CA2515677A1 (fr) | 2004-08-26 |
Family
ID=32872756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002515677A Abandoned CA2515677A1 (fr) | 2003-02-11 | 2004-02-11 | Procedes pour controler in vivo des activites de medicaments |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1592811A2 (fr) |
| AU (1) | AU2004210986A1 (fr) |
| CA (1) | CA2515677A1 (fr) |
| WO (1) | WO2004072265A2 (fr) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006006948A2 (fr) * | 2002-11-14 | 2006-01-19 | Dharmacon, Inc. | Methodes et compositions permettant de selectionner des arnsi presentant une fonctionnalite amelioree |
| US7611839B2 (en) | 2002-11-21 | 2009-11-03 | Wyeth | Methods for diagnosing RCC and other solid tumors |
| US7643943B2 (en) | 2003-02-11 | 2010-01-05 | Wyeth Llc | Methods for monitoring drug activities in vivo |
| US20050287532A9 (en) * | 2003-02-11 | 2005-12-29 | Burczynski Michael E | Methods for monitoring drug activities in vivo |
| CA2523798A1 (fr) * | 2003-04-29 | 2004-11-11 | Wyeth | Procedes de pronostic et de traitement de tumeurs solides |
| WO2006097388A2 (fr) * | 2005-02-08 | 2006-09-21 | Innogenetics N.V. | Variants d'acides nucleiques dans le gene c1qr1 associe a une immunite innee modifiee |
| AU2006270322A1 (en) | 2005-07-14 | 2007-01-25 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
| EP1762575A1 (fr) * | 2005-09-12 | 2007-03-14 | Ganymed Pharmaceuticals AG | Identification d' antigènes associés aux tumeurs pour diagnose et thérapie |
| AU2013206613B2 (en) * | 2005-09-12 | 2017-03-02 | Biontech Ag | Identification of tumor-associated antigens for diagnosis and therapy |
| JP2010509909A (ja) * | 2006-11-16 | 2010-04-02 | ジェントロン リミテッド ライアビリティー カンパニー | 癌診断のための方法、システム、および組成物 |
| CA2770104C (fr) | 2009-08-11 | 2019-03-19 | Opko Curna, Llc | Traitement de maladies associees a l'adiponectine (adipoq) par inhibition du produit de transcription anti-sens naturel d'une adiponectine (adipoq) |
| EP2563764B1 (fr) | 2010-04-26 | 2015-02-25 | Merck Sharp & Dohme Corp. | Nouveaux inhibiteurs de spiropipéridine prolylcarboxypeptidase |
| EP2563127A4 (fr) | 2010-04-27 | 2013-11-06 | Merck Sharp & Dohme | Inhibiteurs de prolylcarboxypeptidase |
| US9365539B2 (en) | 2010-05-11 | 2016-06-14 | Merck Sharp & Dohme Corp. | Prolylcarboxypeptidase inhibitors |
| US8669252B2 (en) | 2010-05-17 | 2014-03-11 | Merck Sharp & Dohme Corp. | Prolylcarboxypeptidase inhibitors |
| EP2579716A4 (fr) | 2010-06-08 | 2014-03-26 | Merck Sharp & Dohme | Nouveaux inhibiteurs de prolylcarboxypeptidase |
| US9006268B2 (en) | 2010-06-11 | 2015-04-14 | Merck Sharp & Dohme Corp. | Prolylcarboxypeptidase inhibitors |
| US20200277669A1 (en) * | 2017-11-15 | 2020-09-03 | The Translational Genomics Research Institute | Biomarker proxy tests and methods for standard blood chemistry tests |
| CN112852964B (zh) * | 2021-03-08 | 2022-02-11 | 镇江市第一人民医院 | 一种环状RNA hsa_circ_0059707及其特异性扩增引物和应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030104371A1 (en) * | 1997-09-24 | 2003-06-05 | Strom Terry B. | Methods of evaluating transplant rejection |
| WO2000040749A2 (fr) * | 1999-01-06 | 2000-07-13 | Genenews Inc. | Technique de detection de transcrits geniques dans le sang et leur utilisation |
| TWI286074B (en) * | 2000-11-15 | 2007-09-01 | Wyeth Corp | Pharmaceutical composition containing CCI-779 as an antineoplastic agent |
| WO2002061144A2 (fr) * | 2001-01-31 | 2002-08-08 | Whitehead Institute For Biomedical Research | Diagnostic de tumeur cerebrale et prediction de resultat de traitement |
| US7611839B2 (en) * | 2002-11-21 | 2009-11-03 | Wyeth | Methods for diagnosing RCC and other solid tumors |
-
2004
- 2004-02-11 CA CA002515677A patent/CA2515677A1/fr not_active Abandoned
- 2004-02-11 EP EP04710266A patent/EP1592811A2/fr not_active Withdrawn
- 2004-02-11 AU AU2004210986A patent/AU2004210986A1/en not_active Withdrawn
- 2004-02-11 WO PCT/US2004/004118 patent/WO2004072265A2/fr active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| AU2004210986A1 (en) | 2004-08-26 |
| WO2004072265A2 (fr) | 2004-08-26 |
| WO2004072265A3 (fr) | 2005-03-03 |
| EP1592811A2 (fr) | 2005-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20210199660A1 (en) | Biomarkers of breast cancer | |
| CA2515677A1 (fr) | Procedes pour controler in vivo des activites de medicaments | |
| Amatschek et al. | Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes | |
| US8017321B2 (en) | Gefitinib sensitivity-related gene expression and products and methods related thereto | |
| EP1824997B1 (fr) | Alterations genetiques utiles pour predire la response de neoplasies malignes a des traitements medicaux bases sur le taxane | |
| US20070198198A1 (en) | Methods and apparatuses for diagnosing AML and MDS | |
| US11591655B2 (en) | Diagnostic transcriptomic biomarkers in inflammatory cardiomyopathies | |
| US20040018513A1 (en) | Classification and prognosis prediction of acute lymphoblastic leukemia by gene expression profiling | |
| AU2004298604B2 (en) | Molecular signature of the PTEN tumor suppressor | |
| US20030190640A1 (en) | Genes expressed in prostate cancer | |
| US20080226645A1 (en) | Methods and compositions for assessment and treatment of asthma | |
| CA2505416A1 (fr) | Methodes de diagnostic de rcc et autres tumeurs solides | |
| US20060240441A1 (en) | Gene expression profiles and methods of use | |
| US20080274906A1 (en) | Novel Predictors of Transplant Rejection Determined by Peripheral Blood Gene-Expression Profiling | |
| US20070134690A1 (en) | Diagnosis of systemic onset juvenile idiopathic arthritis through blood leukocyte microarray analysis | |
| US20050287532A9 (en) | Methods for monitoring drug activities in vivo | |
| CA2531091A1 (fr) | Genes regules dans le cancer de l'ovaire utilises comme cibles pronostique et therapeutique | |
| US20110294686A1 (en) | Egfr inhibitor therapy responsiveness | |
| Kim et al. | Gene cataloging and expression profiling in human gastric cancer cells by expressed sequence tags | |
| KR102422610B1 (ko) | 초기 유방암 환자의 예후 예측 방법 | |
| WO1996034985A1 (fr) | Technique et procede de visualisation de transcrit | |
| Dickinson et al. | Genomic abnormalities in chronic lymphocytic leukemia influence gene expression by a gene dosage effect | |
| EP2385134A1 (fr) | Procédé de pronostic de risque pour leucémie lymphocyte chronique | |
| EP1462527A1 (fr) | Nouveaux marqueurs des affections intestinales inflammatoires | |
| US20060281091A1 (en) | Genes regulated in ovarian cancer a s prognostic and therapeutic targets |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |